The newly funded Building Research in Implementation and Dissemination to close Gaps and achieve Equity in Cancer Control (BRIDGE-C2) Center is one of three National Canc [...]

Pancreatic ductal adenocarcinoma (PDAC) has the lowest 5-year survival rate of all major malignancies (11%). In particular, late-stage malignancies have only a 5% 5-year [...]

Opioid Use Disorder (OUD) is an ongoing epidemic that effects millions of individuals worldwide. There is limited research on OUD in patients with cancer and standardized [...]

The Breast Cancer Decision Aid was tested in a convenience sample of 51, age, risk-appropriate women to provide a preliminary assessment of the impact of the Decision Aid [...]

Prostate-specific antigen (PSA)-based prostate cancer screening recommendations are going through drastic changes. The U.S. Preventive Task Services 2017 (current draft r [...]

Vietnamese American women (VAW) experience cervical cancer diagnoses and death rates that are twice as high as non-Hispanic White women, with later-stage diagnoses compar [...]

Cervical cancer is preventable with well-studied screening interventions and an effective vaccine. For American Indian and/or Alaska Native (AI/AN) people, cervical cance [...]

The Oregon Health & Science University (OHSU) Knight Cancer Institute Mobile Outreach Team is dedicated to addressing cancer disparities by increasing cancer outreach [...]